A change in the executives or directors listed on a Form D tells you that the issuer's disclosed roster of related persons changed between two filings; it does not tell you why, when the change took effect internally, or what it means for how the offering is managed. The filing is a compliance snapshot, not a governance narrative.
This distinction matters because Form D's Item 3, titled Related Persons, is one of the few places investors can see named individuals tied to a private offering without reading a subscription agreement or private placement memorandum. When a name disappears or a new one appears, the instinct is to read it as news: a resignation, a hire, a shake-up. The form itself supports none of those readings on its own.
AltStreet's monitoring flagged such a change in a Form D filed October 1, 2026 by Mascoma Mutual Financial Services Corp (accession 0001661927-26-000003), compared against its prior Form D filed September 9, 2025 (accession 0001470831-25-000170). Two directors were added, one was removed, and the filing's offering terms also changed. Mascoma, a New Hampshire bank holding company that marks the Commercial Banking industry group on both notices, is not a pooled investment fund and is not linked to any platform AltStreet tracks, but the same Item 3 mechanics and the same interpretive limits apply to funds, general partners, and managers that file Form D.
Who appears in Item 3, Related Persons, and why it matters
Item 3 of Form D requires an issuer to list related persons: executive officers, directors, general partners, managing members, and promoters, along with their relationship to the issuer. The SEC's form instructions define these categories by function, not by title alone, so a person can appear as both Executive Officer and Director, as Mascoma's Clayton R. Adams does in both the 2025 and 2026 filings. The filings carry no middle initial for the other directors.
In a private fund context, the issuer on Form D is typically the fund or a parallel vehicle, while Item 3 names tend to be officers and directors of the general partner or managing member rather than individual portfolio managers or investment committee members. A name's absence from Item 3 does not mean that person has no role in the fund; it may simply mean their function does not meet Item 3's defined categories.
The signature block is a separate field from Item 3. Mascoma's 2026 filing is signed by CFO James Williams as the authorized signer, a role distinct from the Item 3 roster of directors. Investors should not assume the signer and the related persons list describe the same set of people or the same point of authority within the organization.
Mascoma's 2026 Form D: what changed from 2025
Comparing the two filings directly shows the mechanics of a roster change. The Form D filed 2025-09-09 (accession 0001470831-25-000170) lists 11 related persons, including Frank Leibly as a director. The Form D filed 2026-10-01 (accession 0001661927-26-000003) lists 12 related persons: Liz Miller and Phil Lapp now appear as directors, and Frank Leibly no longer appears.
Netted against each other, 11 to 12 looks like a one-person increase. It is not. It is two additions and one removal, a detail only visible by comparing names, not counts. This is a general lesson for reading any Form D roster over time: headcount totals can conceal more turnover than they reveal.
The two filings also differ on offering terms. The 2025 notice reported a $25 million offering, fully sold, to 15 investors, with estimated sales commissions of $500,000 and Piper Sandler & Co. named as the recipient. The 2026 notice reports a $35 million offering, fully sold, to 25 investors, with estimated sales commissions of $612,500 and Performance Trust Capital Partners, LLC as the recipient. Item 16 payments, a separate disclosure for payments to executive officers, directors, or promoters, are reported as $0 in both filings. None of these financial figures explain the roster change; they describe a different offering filed under the same issuer and CIK (1661927).
A new name, a missing name, or a new offering: reading the difference correctly
A name appearing for the first time in Item 3 is an observable fact: that person is now listed as a related person on that notice. It is not, by itself, evidence of a new appointment date, an expanded investment mandate, or a change in who controls investment decisions. Confirming any of those requires a source outside Form D, such as a governing document, a press release, or a registration record.
A name's absence is similarly limited in what it proves. It is consistent with a resignation, a term ending, a role falling outside Item 3's categories, or an administrative correction. The filing does not distinguish among these, and nothing in Mascoma's two filings states a reason for Frank Leibly's absence from the 2026 roster.
It also matters whether two filings represent the same offering or different ones. Both Mascoma filings are marked as new notices, not amendments, and they report different offering amounts, investor counts, and commission figures. That makes this a comparison between two separate offerings by the same issuer, not a mid-offering amendment where Item 3 changes would trigger specific SEC amendment requirements. Under Rule 503, an issuer must file an amendment during a continuing offering when related persons are added, while a change limited to an address or similar detail is excepted; a filed amendment refreshes all items, so a changed field is not necessarily the one that triggered the filing.
When to investigate, and how to verify what changed
A roster change is worth investigating further when it is unexplained by any other disclosure, when it coincides with other changes such as a materially different offering size or investor base, or when the same individual's role appears inconsistently across filings. None of these conditions, including Mascoma's larger 2026 offering, establishes that the roster change itself was caused by financial performance, a dispute, or a strategic shift; the filings do not say.
A practical verification workflow starts on EDGAR: confirm the issuer's legal name and CIK, pull both the current and prior Form D filings, and compare Item 3 line by line rather than relying on a total count. For a private fund, check whether the general partner or manager is separately registered on Form ADV, since an investment adviser's reported personnel on IAPD may differ from the issuer's Item 3 roster. Where a placement agent is listed, as Performance Trust Capital Partners, LLC is in Mascoma's 2026 filing, that is a distinct disclosure from Item 3 and concerns compensated solicitation, not governance.
For an RIA or investor with capital already committed, the operative questions sit in the fund's own documents and communications with the manager: when did the change take effect, who currently holds investment authority, have the PPM, limited partnership agreement, or operating agreement been updated, and does any key-person provision apply. Form D cannot answer any of these; it only establishes that the disclosed roster differs between two filing dates.
What this filing does not show
A Form D related-persons comparison does not establish why a name was added or removed, the date the underlying appointment or departure actually took effect, or whether the change reflects a resignation, a term limit, a dismissal, or a clerical correction. Mascoma's filings (accession 0001470831-25-000170, filed 2025-09-09, and accession 0001661927-26-000003, filed 2026-10-01) show the roster difference and nothing about its cause.
The filing also does not establish who holds investment or management authority inside the issuer, general partner, or adviser; Item 3 categories are defined by the form's instructions and do not map directly onto an investment committee, a portfolio management team, or day-to-day control. A zero reported in Item 16 reflects no disclosed payments to executive officers, directors, or promoters in connection with the offering under that item; it is not evidence about total executive compensation generally.
Finally, two Form D filings by the same issuer and CIK are not automatically the same offering. Mascoma's 2025 and 2026 filings are both marked as new notices with different offering amounts, investor counts, and commission estimates, which means this comparison tracks related persons across two distinct offerings rather than incremental changes within one continuing raise. None of this establishes investment performance, fund strategy, or the existence of any key-person event; those require evidence outside Form D, such as fund governing documents, adviser registration records, or direct inquiry to the manager.
Sources
- Mascoma Mutual Financial Services Corp, Form D, October 1, 2026 (0001661927-26-000003) — SEC EDGAR
- Mascoma Mutual Financial Services Corp, Form D, September 9, 2025 (0001470831-25-000170) — SEC EDGAR
- 17 CFR 230.503, Filing of notice of sales (Form D amendments) — eCFR
- Form D (Private Placement) reference — AltStreet
- Mascoma Mutual Financial Services Corp on AltStreet — AltStreet
- Mascoma Mutual Financial Services Corp filing history on EDGAR (CIK 1661927) — SEC EDGAR
- Mascoma Mutual Financial Services Corp entity profile — AltStreet

